The husbandry of pigs for meat production is a constantly developing industry. Most studies 27 on the effects of Ascaris suum infection in pigs and its prevention with anthelmintics are over 28 a decade old. We examined the effect of 2.5 mg fenbendazole per kg bodyweight 29 administered in drinking water for two consecutive days on A. suum infection 1 and 6 weeks 30 after pigs arrived to fattening units. We hypothesised that the treatment would reduce the 31 presence of A. suum-infections, improve the average daily weight gain of pigs, reduce the 32 percentage of liver rejections in pens by 50% and increase the lean meat percentage at 33 slaughter by 1%.
The sum weight of the pigs and their estimated water consumption over an 8 hour period were 144 used to calculate the dosage of 2.5 mg/kg fenbendazole (Panacur AquaSol, MSD Animal 145 Health, NJ, USA) to administer with the dispenser system in the pens of the treatment group 146 (calculated using the application Aquaposo, Intervet International, USA). Similarly, a placebo 147 solution was prepared for the dispenser systems in the pens of the control group. For all pens, 148 water consumption was assumed to be the same for all pigs. The dispenser systems were 149 7 checked before use to verify that all water nipples were working. Before starting the 150 administration of the drug, the last water nipple of both water lines was flushed until the white 151 solution (medication or placebo) could be seen, ensuring that the water line was filled. The 152 administration of the treatment was repeated once more the following day. The researchers 153 and the farmers were blinded to the groups receiving placebo or treatment by using identical 154 containers for both and providing a code with a serial number and either a green or red label. One week before slaughter, which was about 12-13 weeks after arriving at the finishing unit 162 (week 12), the pigs were individually weighed again (Weight 2). Faecal and blood samples 163 were collected from the same animals as in week 1. Each animal was given a tattoo that 164 allowed the slaughterhouse data to be collected post-mortem and to connect the animal to its 165 farm and treatment group. The meat inspection data collected in the slaughterhouse included 166 liver rejections due to more than five milk spots (yes/no) and LMP (measured by AutoFom 167 III, Carometec A/S, Smørum, Denmark). Parasitology and Immunology, Ghent University, Belgium, using an ELISA as described by 177 Vlaminck et al. (2012) . The Hp concentration in serum (mg/L) was determined using a HGB-178 binding assay (Makimura and Suzuki, 1982) and modified using tetramethylbenzidine as 179 chromogen (Alsemgeest et al., 1994) . The sample size necessary for statistical interference (with confidence level 95% and study 193 power 80%) was calculated based on the following hypotheses: treatment with fenbendazole 194 will I) increase the ADWG by at least 20 g/day (SD = 115 g/day), II) increase the LMP by 1% 195 (SD = 3.5%) and III) decrease the liver rejection rate by 50% (from 15% to 7% Four types of model were built to test the hypotheses. The hierarchical structure of the data 204 included farm as a forced fixed factor. Pen was considered a random factor in models that 205 used individual pig data. At the beginning of the study (week 1) and at week 12, mixed linear regression models were 220 used to explore associations between blood parameters and treatment and the presence of A. One farm had to be excluded from the study because the pigs had been relocated during the 233 experiment and the slaughterhouse data could not be obtained at the end of the study. Before At the beginning of the sampling in week 1 (Table 1) , the 427 pigs in the placebo group 238 weighed an average of 38.0 ± 7.5 kg (mean ± SD) and there were 10.4 ± 3.1 animals per pen.
239
The fenbendazole group included 420 pigs with a mean weight of 37.5 ± 7.6 kg, and there 240 were 10.2 ± 2.2 per pen. By the second weighing, 63 animals had left the study (Table 1) .
242
Overall, the proportions of faecal samples containing A. suum eggs were 0.0%, 8.1% and 243 12.5% of the pigs examined at weeks 1, 6 and 12, respectively. At week 6, the group given 244 placebo had 30 pigs with A. suum eggs in the faeces. This increased to 49 pigs at week 12.
245
The group given fenbendazole had two pigs with eggs (EPG = 20) in the faeces at week 6, but 246 no eggs were found at week 12 ( Table 2 ). The number of eggs shed by pigs in the placebo 247 group increased throughout the study, but remained low in the fenbendazole group (Table 2) .
11
Oesophagostomum dentatum eggs were found in one pig in the fenbendazole group at weeks 249 1 and 6 and in one pig from the placebo group at week 1.
251
Clinical blood parameter results can be found in Table 1S . During week 1, five pigs (8.6%) in 252 the placebo group and 12 pigs (20.3%) in the fenbendazole group had an OD value higher 253 than 0.5, which is considered the cut-off point for positive Ascaris samples (Vlaminck et al., 
266
The results of mixed models showed that higher MCHC was associated with the fenbendazole 267 group at week 1 (coefficient = 3.00, 95% CI: 1.45-4.54, P < 0.001). A lower HGB was 268 associated with the presence of Ascaris eggs in faeces at week 12 (coefficient = -6.63, 95% 269 CI: -12.41-(-0.85), P = 0.025). Administrating fenbendazole in water to groups of pigs did not result in a lower ADWG 277 compared to pigs given placebo (Table 2S) . If A. suum eggs were found in the animal's faeces at week 6, the pig gained an average 61.8 281 grams/day less (P = 0.02) than pigs without eggs in the faeces (Table 3S ). This corresponds to 282 a 7.3% lower ADWG in the group with A. suum eggs in the faeces for the 11-12 week period.
283
The model predicted no association between ADWG and eggs in the faeces at week 12 (P = 284 0.36). The number of A. suum eggs in faeces at 6 and 12 weeks did not affect the ADWG (P = 285 0.14 and P = 0.37, respectively). Also, the presence of anti-A. suum antibodies at week 1 or 286 12 did not predict changes in ADWG (P = 0.27 and P = 0.17, respectively). 
Effect of treatment on liver rejections 289
Fewer livers were rejected at slaughter in pens where the pigs were given fenbendazole than 290 in pens with pigs given placebo (OR: 0.18, 95% CI: 0.09-0.37, P < 0.001) ( Table 4S ). The 291 proportion of rejected livers in pigs given placebo was 23.6% (N = 96, 95% CI: 19.7-28.0), 292 while in pigs give fenbendazole it was 7.3% (N = 29, 95% CI: 5.0-10.1; Fig. 1 ). The 293 reduction in the proportion of liver rejections between groups was 69.8% (95% CI: 60.1- Treatment did not affect the LMP, but there were differences between farms (Table 5S, 4. Discussion 301 We tested whether administrating 2.5 mg fenbendazole per kg pig bodyweight in drinking 302 water for 2 consecutive days during weeks 1 and 6 after arriving at the finishing unit will 303 reduce the presence of A. suum in the faeces, increase ADWG, reduce the number of livers 304 rejected and increase LMP at slaughter. (Table 2 ). This was supported by an increase in the number 314 of pigs with a humoral response to A. suum infection in the placebo group, mainly in farm 1 315 and 2 (Fig. 1S) . It is however not clear whether the seroconversion is attributed to exposure to 316 the parasite prior to the study or due to exposure from new infections. Overall, the results 317 support the hypothesis that fenbendazole treatment in the water supply will reduce the 318 presence of A. suum eggs in faeces. Treatment with fenbendazole did not improve the ADWG. The assumption of lower weight 322 gain would depend on the presence of adult worms parasitising the pigs' guts. Since A. suum 323 eggs were first found in pig faeces at week 6, it is possible that the adult worms were not 324 present long enough in the placebo group and at sufficient numbers to produce an effect on 325 weight gain between the treatment groups. However, we did find that A. suum can affect 326 weight gain. When using the presence of A. suum eggs in the faeces of individual pigs as a 327 predictor for ADWG at week 6, there was a negative association. Pigs with eggs in the faeces 328 had an ADWG that was 61.8 grams/day lower for the 12 week period than pigs without eggs 329 in the faeces. The mean weight at slaughter was 7.3% lower for pigs with A. suum in the 330 faeces at week 6. The finding is in contrast to results from a study that experimentally infected 331 pigs three times with 2,000 A. suum eggs 11 days apart followed by fenbendazole treatment 332 (Stewart et al., 1985) . That study found no differences in ADWG, feed-conversion efficiency 333 or in histology of the lungs and livers. Support for our study can be found in investigations In pigs previously exposed to A. suum under experimental conditions, 90% fewer larvae 343 reached the small intestine because of acquired immunity (Jungersen et al., 1999) . However, 344 the presence of adult larvae in the intestine did not affect the protective immunity. We found 345 humoral evidence of infection throughout the study. The placebo group had more pigs 346 seroconverting during the experiment, while no new pigs seroconverted in the fenbendazole 347 group. It appears that pigs in the fenbendazole group did not end up hosting adult nematodes 348 within the observation period, with the exception of two pigs during week 6. These two pigs 349 were both from the same farm and pen, and it is possible these pigs did not get effective 350 treatment during week 1. We did not find evidence that previous exposure to A. suum could 351 be associated with differences in ADWG. This is in contrast to a recent study using the same have time to heal before slaughter. The data showed that pigs in both groups were exposed to 362 parasites during the study (Table 1S , Fig. 1S ), but eggs were almost exclusively found in the 363 placebo group (Table 2) . This meant that larvae migration likely did occur in both groups, but 364 the difference was likely the continuous infection pressure in the placebo group.
365
Individual data on liver rejections and LMP would have allowed us to link the slaughterhouse 366 data with the infection status of the individual animal, but this proved to not be possible. As a 367 consequence, the data were analysed at pen level for the two groups.
368
The study farms had a history of at least 15% liver rejections because of A. suum liver spots.
369
In pens that were administrated fenbendazole in the water, 69.8% fewer livers were rejected 370 than in placebo pens. This is similar to what has been described previously (Stewart et al., 371 16 1984) . The result of this study thus proved the hypothesis that the treatment could lower the 372 liver rejection rate at slaughter by at least 50%. (Steward et al., 1984) . We found, however, that treatment with 383 fenbendazole did not affect LMP, and the hypothesis was rejected. Our results were likely 384 affected by the proportion of pigs that hosted adult, egg-shedding helminths. At all three time 385 points in this study, 13.9% of the pigs had A. suum eggs in their faeces.
387
When investigating the potential benefits of treatments in pigs, the technical aspects of how 388 the outcome is measured should be considered that determine the economic benefit to the 389 farmer. In the case of LMP, the value is generated by an instrument with a tolerated error of We chose to administer fenbendazole in the water because this is more practical for the farmer 398 than administering it as powder in the feed. It is also a new way of delivering anthelmintics to 399 pigs. Our results indicate that the mode of administration and the effect of the drug had the 400 desired effect (Table 2) , and can be an option if pig liver rejection rates on a farm are higher 401 than the average. To account for factors that could influence the groups, the pigs were of the same breed and 411 were raised at the same time and in the same rooms. Weight and blood data (Table 1S) 412 indicated that we were successful in creating two similar treatment groups. A fifth farm was 413 excluded from the study because slaughterhouse data could not be obtained and because the 414 criteria that were set for the study were not met. This meant that the planned sample size was 415 not met and, for the hypothesis examining the effect of treatment on ADWG, the study power 416 was reduced to 68%. The remaining sample size goals were met. 
Conclusion

419
Treatment of pigs with 2.5 mg fenbendazole per kg bodyweight for 2 consecutive days 1 and 420 6 weeks after arriving at the finishing unit reduced the presence of A. suum eggs in faeces. In 421 pens receiving the treatment, 69.8% fewer livers were rejected at slaughter. Pigs with A. suum 422 in faeces 6 weeks after arriving at the finishing unit exhibited ADWGs that were 61.8 g/day 423 lower than those exhibited by pigs with no eggs over a 12 week period. Treatment with 424 fenbendazole could not be associated with a change in ADWG and did not have a measurable 425 effect on LMP. Table 1 . 553 Number of animals and samples at the beginning (week 1) and end (week 12) of the study. P 554 = N pigs in study, F = N faecal samples collected, B = N blood samples collected. Table 1S . 559 Mean ± SD of clinical blood parameters in pigs receiving placebo (P) or fenbendazole (T) at 560 weeks 1 and 6 after arrival into the finishing herd. The blood samples were taken during 561 weeks 1 and 12.
562
Week 1
Week 1 566 Table 2 . 567 The presence and mean egg counts of A. suum eggs in faeces 1, 6 and 12 weeks after entering 568 the fattening unit. P = placebo group, T = treatment group, EPG = eggs per gram faeces. Observations: 79, model P-value <0.001, Wald chi 2 = 81.55. 
